Mirogabalin in Japanese Patients with Renal Impairment and Pain Associated with Diabetic Peripheral Neuropathy or Post-Herpetic Neuralgia: A Phase III, Open-Label, 14-Week Study

por Baba, Masayuki, Takatsuna, Hiroshi, Matsui, Norimitsu, Ohwada, Shoichi
Publicado 2020

Mirogabalin for the treatment of diabetic peripheral neuropathic pain: A randomized, double‐blind, placebo‐controlled phase III study in Asian patients

por Baba, Masayuki, Matsui, Norimitsu, Kuroha, Masanori, Wasaki, Yosuke, Ohwada, Shoichi
Publicado 2019

Results of Mirogabalin Treatment for Diabetic Peripheral Neuropathic Pain in Asian Subjects: A Phase 2, Double-Blind, Randomized, Placebo-Controlled, Study

por Baba, Masayuki, Kuroha, Masanori, Ohwada, Shoichi, Murayama, Emiko, Matsui, Norimitsu
Publicado 2020

Long‐term safety and efficacy of mirogabalin in Asian patients with diabetic peripheral neuropathic pain

por Baba, Masayuki, Matsui, Norimitsu, Kuroha, Masanori, Wasaki, Yosuke, Ohwada, Shoichi
Publicado 2019

Long-term safety and efficacy of mirogabalin in Asian patients with postherpetic neuralgia: Results from an open-label extension of a multicenter randomized, double-blind, placebo-...

por Kato, Jitsu, Matsui, Norimitsu, Kakehi, Yoshihiro, Murayama, Emiko, Ohwada, Shoichi
Publicado 2020

Mirogabalin for the management of postherpetic neuralgia: a randomized, double-blind, placebo-controlled phase 3 study in Asian patients

por Kato, Jitsu, Matsui, Norimitsu, Kakehi, Yoshihiro, Murayama, Emiko, Ohwada, Shoichi, Sugihara, Masahiro
Publicado 2019

Tolerability, pharmacokinetics, and pharmacodynamics of mirogabalin in healthy subjects: Results from phase 1 studies

por Brown, Karen, Mendell, Jeanne, Ohwada, Shoichi, Hsu, Ching, He, Ling, Warren, Vance, Dishy, Victor, Zahir, Hamim
Publicado 2018

Phase 1 study of new formulation of patritumab (U3-1287) Process 2, a fully human anti-HER3 monoclonal antibody in combination with erlotinib in Japanese patients with advanced non...

por Shimizu, Toshio, Yonesaka, Kimio, Hayashi, Hidetoshi, Iwasa, Tsutomu, Haratani, Koji, Yamada, Hironori, Ohwada, Shoichi, Kamiyama, Emi, Nakagawa, Kazuhiko
Publicado 2017

Patritumab plus trastuzumab and paclitaxel in human epidermal growth factor receptor 2‐overexpressing metastatic breast cancer

por Mukai, Hirofumi, Saeki, Toshiaki, Aogi, Kenjiro, Naito, Yoichi, Matsubara, Nobuaki, Shigekawa, Takashi, Ueda, Shigeto, Takashima, Seiki, Hara, Fumikata, Yamashita, Tomonari, Ohwada, Shoichi, Sasaki, Yasutsuna
Publicado 2016

Phase 1 study of DS‐1205c combined with gefitinib for EGFR mutation‐positive non‐small cell lung cancer

por Goto, Koichi, Shiraishi, Yoshimasa, Murakami, Haruyasu, Horinouchi, Hidehito, Toyozawa, Ryo, Takeda, Masayuki, Uno, Makiko, Crawford, Nigel, McGill, Joseph, Jimbo, Takeshi, Ishigami, Masato, Takayama, Gensuke, Nakayama, Shintaro, Ohwada, Shoichi, Nishio, Makoto
Publicado 2023